We serve Chemical Name:Xanthiazone CAS:212701-97-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Xanthiazone
CAS.NO:212701-97-8
Synonyms:2H-1,4-Benzothiazine-3,5-dione, 4,8-dihydro-7-(hydroxymethyl)-8,8-dimethyl-;7-(Hydroxymethyl)-8,8-dimethyl-4,8-dihydro-2H-1,4-benzothiazine-3,5-dione;Xanthiazone
Molecular Formula:C11H13NO3S
Molecular Weight:239.291
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:516.6±50.0 °C at 760 mmHg
Density:1.4±0.1 g/cm3
Index of Refraction:1.629
PSA:
Exact Mass:239.061615
LogP:1.96
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2H-1,4-Benzothiazine-3,5-dione, 4,8-dihydro-7-(hydroxymethyl)-8,8-dimethyl- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Xanthiazone physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2H-1,4-Benzothiazine-3,5-dione, 4,8-dihydro-7-(hydroxymethyl)-8,8-dimethyl- Use and application,Xanthiazone technical grade,usp/ep/jp grade.
Related News: The three products for which it received the PLI approvals are betamethasone with a production capacity of 12 MT at an investment of Rs 31.43 crore, dexamethasone of 10 MT with an investment of Rs. 26.19 crore and prednisolone of 15 MT at Rs 39. 29 crore. This takes the total investment to Rs 96.91 core. 2-fluoro-1,4-diazaspiro[4.5]decan-8-one manufacturers Brian McNamara, currently head of GSK’s consumer healthcare division, will continue to serve as the franchise’s CEO after it breaks away from GSK in 2022, the British pharma said Thursday. ethyl 7-chloro-1,2-dihydro-2-oxo-6-(4-((phenylcarbamoyloxy)methyl)imidazole-1-yl)quinoline-3-carboxylate suppliers Elliott made its intention for a C-suite overhaul clear in an open letter early July. The activist investor called on GSK to appoint a new board directors with biopharma and consumer health expertise to select the leaders for the two companies. 2-methoxy-1-(2-methylbutoxy)-4-[(E)-prop-1-enyl]benzene vendor & factory Many specialty and biotech organizations are now relying on external service providers to minimize the costs of manufacturing and in-house development required to develop molecules for new drugs and their subsequent clinical trials, explains Saurabh Gurnurkar, executive director, UQUIFA. ,The three products for which it received the PLI approvals are betamethasone with a production capacity of 12 MT at an investment of Rs 31.43 crore, dexamethasone of 10 MT with an investment of Rs. 26.19 crore and prednisolone of 15 MT at Rs 39. 29 crore. This takes the total investment to Rs 96.91 core.
